| AB001. OS01. 01. Post op radiation may be detrimental in thymoma but not in thymic carcinoma tumors FMS Kong, W Wang, Y Zang, H Zhang, J Smith, S Badve, K Kesler, ... Mediastinum 1 (9), 2017 | 357 | 2017 |
| Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non–small-cell lung cancer: a phase 2 clinical trial FM Kong, RK Ten Haken, M Schipper, KA Frey, J Hayman, M Gross, ... JAMA oncology 3 (10), 1358-1365, 2017 | 208 | 2017 |
| Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect? JY Jin, A Gu, W Wang, NL Oleinick, M Machtay Radiotherapy and Oncology 149, 55-62, 2020 | 103 | 2020 |
| IDO immune status after chemoradiation may predict survival in lung cancer patients W Wang, L Huang, JY Jin, S Jolly, Y Zang, H Wu, L Yan, W Pi, L Li, ... Cancer research 78 (3), 809-816, 2018 | 60 | 2018 |
| Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning W Wang, Y Xu, M Schipper, MM Matuszak, T Ritter, Y Cao, RK Ten Haken International Journal of Radiation Oncology* Biology* Physics 86 (5), 956-963, 2013 | 59 | 2013 |
| AB006. OS01. 06. Factors associated with survival in patients with thymoma: study of 523 cases from one institution H Zhang, W Wang, K Kesler, M Kalra, PJ Loehrer Mediastinum 1 (9), 2017 | 56 | 2017 |
| Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer J Xue, C Han, A Jackson, C Hu, H Yao, W Wang, J Hayman, W Chen, ... Radiotherapy and Oncology 133, 213-219, 2019 | 33 | 2019 |
| A framework for modeling radiation induced lymphopenia in radiotherapy JY Jin, T Mereniuk, A Yalamanchali, W Wang, M Machtay, S Ellsworth Radiotherapy and Oncology 144, 105-113, 2020 | 32 | 2020 |
| Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer Y Liu, W Wang, K Shiue, H Yao, A Cerra-Franco, RH Shapiro, KC Huang, ... Radiotherapy and Oncology 156, 231-238, 2021 | 29 | 2021 |
| Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer C Zhang, L Ye, S Guan, S Jin, W Wang, S Sun, KH Lee, J Wei, B Liu Tumor Biology 35, 2047-2051, 2014 | 27 | 2014 |
| Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancer CB Han, WL Wang, L Quint, JX Xue, M Matuszak, R Ten Haken International Journal of Radiation Oncology* Biology* Physics 89 (2), 313-321, 2014 | 26 | 2014 |
| Machine learning to build and validate a model for radiation pneumonitis prediction in patients with non–small cell lung cancer H Yu, H Wu, W Wang, S Jolly, JY Jin, C Hu, FM Kong Clinical Cancer Research 25 (14), 4343-4350, 2019 | 25 | 2019 |
| Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer FMS Kong, L Li, W Wang, J Campbell, JL Waller, M Piert, M Gross, ... Radiotherapy and Oncology 132, 241-249, 2019 | 25 | 2019 |
| Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer W Wang, S Guan, S Sun, Y Jin, KH Lee, Y Chen, J Wei Tumor Biology 35, 4901-4905, 2014 | 24 | 2014 |
| Use a survival model to correlate single-nucleotide polymorphisms of DNA repair genes with radiation dose–response in patients with non-small cell lung cancer JY Jin, W Wang, RK Ten Haken, J Chen, N Bi, R Sadek, H Zhang, ... Radiotherapy and Oncology 117 (1), 77-82, 2015 | 23 | 2015 |
| A validation study on IDO immune biomarkers for survival prediction in non–small cell lung cancer: radiation dose fractionation effect in early-stage disease W Wang, L Huang, JY Jin, W Pi, SG Ellsworth, S Jolly, AL Mellor, ... Clinical Cancer Research 26 (1), 282-289, 2020 | 19 | 2020 |
| Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapy SG Ellsworth, BM Rabatic, J Chen, J Zhao, J Campbell, W Wang, W Pi, ... PloS one 12 (9), e0183239, 2017 | 19 | 2017 |
| A phase II trial of mid-treatment FDG-PET adaptive, individualized radiation therapy plus concurrent chemotherapy in patients with non-small cell lung cancer (NSCLC). F Kong, RK Ten Haken, MJ Schipper, J Hayman, N Ramnath, KA Hassan, ... Journal of Clinical Oncology 31 (15_suppl), 7522-7522, 2013 | 18 | 2013 |
| Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer F Chen, JY Jin, TSK Hui, H Jing, H Zhang, Y Nong, Y Han, W Wang, L Ma, ... Frontiers in oncology 12, 768956, 2022 | 16 | 2022 |
| Circulating Antibodies to Linear Peptide Antigens Derived from ANXA1 and FOXP3 in Lung Cancer W WANG, WEN ZHONG, C CHEN, Q MENG, JUN WEI Anticancer Research 37 (6), 3151-3155, 2017 | 11 | 2017 |
Feng-Ming (Spring) KongThe University of Hong KongVerified email at hku.hk
